157 related articles for article (PubMed ID: 17113202)
1. FLK-1-based minigene vaccines induce T cell-mediated suppression of angiogenesis and tumor protective immunity in syngeneic BALB/c mice.
Luo Y; Markowitz D; Xiang R; Zhou H; Reisfeld RA
Vaccine; 2007 Feb; 25(8):1409-15. PubMed ID: 17113202
[TBL] [Abstract][Full Text] [Related]
2. A Legumain-based minigene vaccine targets the tumor stroma and suppresses breast cancer growth and angiogenesis.
Lewēn S; Zhou H; Hu HD; Cheng T; Markowitz D; Reisfeld RA; Xiang R; Luo Y
Cancer Immunol Immunother; 2008 Apr; 57(4):507-15. PubMed ID: 17786443
[TBL] [Abstract][Full Text] [Related]
3. T cell-mediated suppression of angiogenesis results in tumor protective immunity.
Zhou H; Luo Y; Mizutani M; Mizutani N; Reisfeld RA; Xiang R
Blood; 2005 Sep; 106(6):2026-32. PubMed ID: 15920006
[TBL] [Abstract][Full Text] [Related]
4. Construction of a DNA vaccine encoding Flk-1 extracellular domain and C3d fusion gene and investigation of its suppressing effect on tumor growth.
Liang PH; Zhang KQ; Xu GL; Li YF; Wang LF; Nie ZL; Ye J; Wu G; Ge CG; Jin FS
Cancer Immunol Immunother; 2010 Jan; 59(1):93-101. PubMed ID: 19543726
[TBL] [Abstract][Full Text] [Related]
5. Transcription factor Fos-related antigen 1 is an effective target for a breast cancer vaccine.
Luo Y; Zhou H; Mizutani M; Mizutani N; Reisfeld RA; Xiang R
Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8850-5. PubMed ID: 12857959
[TBL] [Abstract][Full Text] [Related]
6. Endoglin (CD105) is a target for an oral DNA vaccine against breast cancer.
Lee SH; Mizutani N; Mizutani M; Luo Y; Zhou H; Kaplan C; Kim SW; Xiang R; Reisfeld RA
Cancer Immunol Immunother; 2006 Dec; 55(12):1565-74. PubMed ID: 16565828
[TBL] [Abstract][Full Text] [Related]
7. Enhanced antimetastatic effect of fetal liver kinase 1 extracellular domain and interferon-gamma fusion gene-modified dendritic cell vaccination.
Pan J; Heiser A; Marget M; Steinmann J; Kabelitz D
Gene Ther; 2005 May; 12(9):742-50. PubMed ID: 15729371
[TBL] [Abstract][Full Text] [Related]
8. DNA vaccines designed to inhibit tumor growth by suppression of angiogenesis.
Reisfeld RA; Niethammer AG; Luo Y; Xiang R
Int Arch Allergy Immunol; 2004 Mar; 133(3):295-304. PubMed ID: 14988601
[TBL] [Abstract][Full Text] [Related]
9. DNA vaccines suppress tumor growth and metastases by the induction of anti-angiogenesis.
Reisfeld RA; Niethammer AG; Luo Y; Xiang R
Immunol Rev; 2004 Jun; 199():181-90. PubMed ID: 15233734
[TBL] [Abstract][Full Text] [Related]
10. [Construction of a DNA vaccine against extracellular domain 1-3 of Flk1 and its inhibitory effect on growth of liver cancer cell line H22].
Lu F; Qin ZY; Li YM; Qi YX; Liu YF; Yang WB
Ai Zheng; 2004 Dec; 23(12):1616-21. PubMed ID: 15601548
[TBL] [Abstract][Full Text] [Related]
11. Antiangiogenic tumor therapy by DNA vaccine inducing aquaporin-1-specific CTL based on ubiquitin-proteasome system in mice.
Chou B; Hiromatsu K; Okano S; Ishii K; Duan X; Sakai T; Murata S; Tanaka K; Himeno K
J Immunol; 2012 Aug; 189(4):1618-26. PubMed ID: 22802414
[TBL] [Abstract][Full Text] [Related]
12. Oral DNA vaccines target the tumor vasculature and microenvironment and suppress tumor growth and metastasis.
Xiang R; Luo Y; Niethammer AG; Reisfeld RA
Immunol Rev; 2008 Apr; 222():117-28. PubMed ID: 18363997
[TBL] [Abstract][Full Text] [Related]
13. Mice vaccination with interleukin 12-transduced colon cancer cells potentiates rejection of syngeneic non-organ-related tumor cells.
Adris S; Chuluyan E; Bravo A; Berenstein M; Klein S; Jasnis M; Carbone C; Chernajovsky Y; Podhajcer OL
Cancer Res; 2000 Dec; 60(23):6696-703. PubMed ID: 11118055
[TBL] [Abstract][Full Text] [Related]
14. A DNA vaccine targeting Fos-related antigen 1 enhanced by IL-18 induces long-lived T-cell memory against tumor recurrence.
Luo Y; Zhou H; Mizutani M; Mizutani N; Liu C; Xiang R; Reisfeld RA
Cancer Res; 2005 Apr; 65(8):3419-27. PubMed ID: 15833877
[TBL] [Abstract][Full Text] [Related]
15. Immunity against tumor angiogenesis induced by a fusion vaccine with murine beta-defensin 2 and mFlk-1.
Wang YS; Wang GQ; Wen YJ; Wang L; Chen XC; Chen P; Kan B; Li J; Huang C; Lu Y; Zhou Q; Xu N; Li D; Fan LY; Yi T; Wu HB; Wei YQ
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6779-87. PubMed ID: 18006780
[TBL] [Abstract][Full Text] [Related]
16. An anti-vascular endothelial growth factor receptor 2/fetal liver kinase-1 Listeria monocytogenes anti-angiogenesis cancer vaccine for the treatment of primary and metastatic Her-2/neu+ breast tumors in a mouse model.
Seavey MM; Maciag PC; Al-Rawi N; Sewell D; Paterson Y
J Immunol; 2009 May; 182(9):5537-46. PubMed ID: 19380802
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2.
Liu JY; Wei YQ; Yang L; Zhao X; Tian L; Hou JM; Niu T; Liu F; Jiang Y; Hu B; Wu Y; Su JM; Lou YY; He QM; Wen YJ; Yang JL; Kan B; Mao YQ; Luo F; Peng F
Blood; 2003 Sep; 102(5):1815-23. PubMed ID: 12750177
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic antitumor potential of endoglin-based DNA vaccine combined with immunomodulatory agents.
Jarosz M; Jazowiecka-Rakus J; Cichoń T; Głowala-Kosińska M; Smolarczyk R; Smagur A; Malina S; Sochanik A; Szala S
Gene Ther; 2013 Mar; 20(3):262-73. PubMed ID: 22495576
[TBL] [Abstract][Full Text] [Related]
19. A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth.
Niethammer AG; Xiang R; Becker JC; Wodrich H; Pertl U; Karsten G; Eliceiri BP; Reisfeld RA
Nat Med; 2002 Dec; 8(12):1369-75. PubMed ID: 12415261
[TBL] [Abstract][Full Text] [Related]
20. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
Pan JP; Weng YS; Wu QQ
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
